Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|February 1, 1995
Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?K D Lindor, C H Janes, J S Crippin, et al.Hepatology (Baltimore, Md.)|June 1, 1996
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot studyJ Laurin, K D Lindor, J S Crippin, et al.Hepatology (Baltimore, Md.)|May 1, 1992
Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?J S Crippin, K D Lindor, R Jorgensen, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
A consolidated biovigilance system for blood, tissue and organs: one size does not fit allT L Pruett, E A Blumberg, D J Cohen, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 31, 2011
Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosisH I Basha, V Subramanian, A Seetharam, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 9, 2000
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patientsG Testa, J S Crippin, G J Netto, et al.Hepatology (Baltimore, Md.)|July 10, 1998
Optimal timing of liver transplantation for primary biliary cirrhosisW R Kim, R H Wiesner, T M Therneau, et al.Hepatology (Baltimore, Md.)|January 27, 1999
Quality of life before and after liver transplantation for cholestatic liver diseaseC R Gross, M Malinchoc, W R Kim, et al.Transplantation|December 10, 1998
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?D R Jeyarajah, G J Netto, S P Lee, et al.Hepatology (Baltimore, Md.)|March 1, 1997
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver diseaseP Ricci, T M Therneau, M Malinchoc, et al.Pageof 3